Renal denervation offers a potentially transformative and minimally invasive option for treating hypertension. With this ...

Boston Scientific looks to catch up with Medtronic and Recor Medical in the much-hyped renal denervation space with its ...

Medtronic VP Jason Fontana offered advice for other device developers who might one day be looking for their own NCA.

Albany, NY (WRGB) — Albany Medical Center is now offering a new procedure aimed at helping patients with resistant hypertension, a condition where traditional medications fail to adequately lower ...

Boston Scientific is diving into the field of renal denervation, with a $540 million deal for SoniVie and its ultrasound-based therapy for stubbornly high blood pressure. The acquisition sets up ...

The move aims to broaden interventional cardiology therapies with ultrasound-based renal denervation therapy to treat hypertension. The transaction is expected to be completed in the first half of ...

The needles release small amounts of alcohol that destroy the renal nerves (sympathetic denervation). The aim is to lower blood pressure. You should be included in making decisions about your care.

Boston Scientific, Inc. BSX has signed a definitive agreement to acquire SoniVie Ltd., a privately held medical device company that developed the TIVUS Intravascular Ultrasound System. The company ...

Marlborough medical device manufacturer Boston Scientific has entered into a purchase agreement worth up to half a billion dollars to acquire SoniVie, an Israel-headquartered medical device company ...

Boston Scientific (BSX) has agreed to acquire medical device company SoniVie for around $360M upfront payment.